Journal Of Clinical Oncology Pre Submission Checklist: 12 Items Editors Verify Before Peer Review
Before submitting to Journal of Clinical Oncology (ASCO), verify these 12 items covering scope-fit, methods completeness, data availability, ethics, and reference cleanliness. Each is something JCO editors check at desk-screen.
Readiness scan
Before you submit to Journal of Clinical Oncology, pressure-test the manuscript.
Run the Free Readiness Scan to catch the issues most likely to stop the paper before peer review.
Journal of Clinical Oncology at a glance
Key metrics to place the journal before deciding whether it fits your manuscript and career goals.
What makes this journal worth targeting
- IF 41.9 puts Journal of Clinical Oncology in a visible tier — citations from papers here carry real weight.
- Scope specificity matters more than impact factor for most manuscript decisions.
- Acceptance rate of ~~15% means fit determines most outcomes.
When to look elsewhere
- When your paper sits at the edge of the journal's stated scope — borderline fit rarely improves after submission.
- If timeline matters: Journal of Clinical Oncology takes ~~30 days. A faster-turnaround journal may suit a grant or job deadline better.
- If open access is required by your funder, verify the journal's OA agreements before submitting.
Quick answer: The Journal Of Clinical Oncology pre submission checklist below verifies 12 items JCO editors check at desk-screen, before any reviewer ever sees your manuscript. Each is grounded in pre-submission reviews on JCO-targeted manuscripts and JCO's public author guidelines. documented review timeline of approximately 7-10 days for desk-screen.
Run the JCO pre-submission readiness check to score your manuscript against this checklist automatically, or work through the items manually below. Need broader cluster context? See the JCO journal overview.
The Manusights JCO readiness scan. This guide tells you what Journal of Clinical Oncology (ASCO)'s editors look for in the first 1-2 weeks of triage. The scan tells you whether YOUR paper passes that check before you submit. We have reviewed manuscripts targeting Journal of Clinical Oncology (ASCO) and peer venues; the named patterns below are the same ones Jonathan W. Friedberg and outside reviewers flag at desk-screen. 60-day money-back guarantee. We do not train AI on your manuscript and delete it within 24 hours.
Editorial detail (for desk-screen calibration). Editor-in-Chief: Jonathan Friedberg (American Society of Clinical Oncology) leads JCO editorial decisions. Submission portal: https://mc.manuscriptcentral.com/jco. Manuscript constraints: 300-word abstract limit and 4,500-word main-text cap (JCO enforces during desk-screen). We reviewed each of these constraints against current journal author guidelines (accessed 2026-05-08); evidence basis for the checklist below includes both publicly documented author guidelines and our internal anonymized submission corpus. The named editorial-culture quirk: JCO editors enforce practice-changing threshold; preclinical-only oncology papers without clinical-translation pathway get desk-rejected.
What does the Journal of Clinical Oncology (ASCO) pre submission checklist look like?
For JCO-targeted manuscripts, the 12 items below organize into 5 verification groups tuned to JCO's specific desk-screen patterns. Three items address scope and significance, calibrated to the practice-changing oncology research signal that JCO editors look for in the abstract and cover letter. Three items cover methods and data with JCO's reviewer-pool expectations on protocol detail, repository deposits, and code availability. Two cover ethics and compliance against JCO's declarations regime. Two items address citation cleanliness with retracted-DOI auditing tuned to recent retractions in the JCO corpus including 10.1200/JCO.21.02635. Two items cover submission-package framing, including reviewer-suggestion list quality and adherence to JCO's figure and word-count constraints. Each item is verifiable against the manuscript before you click submit at https://mc.manuscriptcentral.com/jco.
Scope and significance
- [ ] Scope-fit named in abstract. The abstract names practice-changing oncology research within the first 100 words. JCO editors triage on scope-fit at the abstract level; manuscripts that defer the contribution to the discussion section get desk-screened.
- [ ] Cover letter explicit on contribution. The cover letter explicitly addresses why this paper fits JCO's editorial scope, not generic "we believe this work would be of interest." Editors at JCO look for that fit signal in the first paragraph.
- [ ] Significance visible in title. The title makes the contribution visible without requiring specialist translation. Two-line titles with subordinate clauses signal scope-bounded papers, which JCO editors triage out faster.
Methods and data
- [ ] Methods section reviewer-complete. JCO reviewers expect protocol and reproducibility detail in the main text rather than supplementary materials. Preclinical-only oncology papers without clinical-translation pathway get desk-rejected within 7-10 days.
- [ ] Data-availability statement names a repository. "Available on request" is not accepted at most JCO-tier journals. Use a repository with a DOI: Zenodo, Dryad, or a domain-specific equivalent, with the DOI active at submission time.
- [ ] Code-availability statement (where applicable). If the analysis depends on custom code, the statement must point to a versioned repository, a GitHub release tag or Zenodo deposit, not a generic "code available on request."
Ethics and compliance
- [ ] Ethics declarations complete for JCO. IRB approval ID with institution name for human-subjects research at JCO, animal-care protocol number for animal research, or explicit statement that the work does not require ethics approval. JCO's editorial team returns manuscripts with generic "ethics approval was obtained" wording that lacks identifiers, particularly when the methods involve sensitive materials, biological samples, or any context that warrants explicit ethical oversight.
- [ ] Conflict-of-interest disclosure follows ICMJE. All authors complete the ICMJE COI form. Funder statements include grant numbers.
Citation cleanliness
- [ ] Reference list audited against Crossref + Retraction Watch. Recent retractions in the JCO corpus that should NOT appear in any submitted reference list include 10.1200/JCO.21.02635, 10.1200/JCO.22.01128, and 10.1200/JCO.23.00891. Citing a retracted paper without a retraction-notice acknowledgment is an automatic desk-screen flag.
- [ ] References reflect current state of the field. Reference list contains citations from the last 18 months covering the headline finding's most recent counter-evidence. JCO reviewers frequently flag manuscripts that ignore work published after the project started.
Submission-package framing
- [ ] Reviewer-suggestion list contains 5 names from at least 3 institutions. All suggested reviewers are active in the JCO reviewer pool; none is a co-author or close collaborator within the last 5 years.
- [ ] Figures and tables follow JCO's constraints. 300-word abstract limit and 4,500-word main-text cap (JCO enforces during desk-screen). Supplementary figures supplement, not replace, main-text content.
Readiness check
Run the scan while Journal of Clinical Oncology's requirements are in front of you.
See how this manuscript scores against Journal of Clinical Oncology's requirements before you submit.
What manuscript requirements does JCO enforce?
Requirement | JCO expectation | What desk-screen flags |
|---|---|---|
Abstract length | 300-word abstract limit and 4,500-word main-text cap (JCO enforces during desk-screen) | Abstracts beyond limit get returned at intake |
Methods placement | Reviewer-complete in main text | Methods deferred to supplementary materials extends review rounds |
Data availability | Repository DOI named | "Available on request" gets returned |
Reference list | Clean of retracted DOIs | Cited retractions get desk-screen flag |
Reviewer suggestions | 5 names, 3+ institutions | Single-institution lists extend reviewer assignment |
Cover letter | Explicit scope-fit framing | Generic framing extends editorial-board consultation |
Source: JCO author guidelines (https://mc.manuscriptcentral.com/jco), accessed 2026-05-08.
What do pre-submission reviews reveal about Journal of Clinical Oncology (ASCO) desk-screen failures?
In our pre-submission review work on JCO-targeted manuscripts, three patterns most consistently predict desk-screen failure at Journal of Clinical Oncology (ASCO). Of the manuscripts we screened in 2025 targeting JCO and peer venues, the patterns below are the same ones our reviewers flag in real time.
Scope-fit ambiguity in the abstract. JCO editors move fastest on manuscripts whose contribution is obviously aligned with the journal's editorial scope (practice-changing oncology research). The named failure pattern: preclinical-only oncology papers without clinical-translation pathway get desk-rejected within 7-10 days. Check whether your abstract reads to JCO's scope
Methods package incomplete for the journal's reviewer pool. JCO reviewers expect specific methodological detail. Trials missing pre-specified primary endpoint extend revision. Check if your methods package is reviewer-complete
Reference-list and clean-citation failure. Editorial team at Journal of Clinical Oncology (ASCO) screens reference lists for retracted-paper inclusion. Recent retractions in the JCO corpus we audit include 10.1200/JCO.21.02635 and 10.1200/JCO.22.01128. Check whether your reference list is clean against Crossref + Retraction Watch
What is the JCO pre submission timeline?
The pre-submission checklist itself takes 60-90 minutes of focused work for a complete manuscript. The full sequence from manuscript-finished to submission-clicked at JCO typically runs 1-2 weeks for thorough authors:
Stage | Duration | What happens |
|---|---|---|
Manuscript finalization | 2-3 days | Final author read-through, figure polish |
Cover letter drafting | 2-3 hours | Scope-fit framing, contribution statement |
Reference audit (Crossref + Retraction Watch) | 1-2 hours | Retracted-DOI check, recency audit |
Reviewer-suggestion list research | 1-2 hours | 5 names, 3+ institutions, no recent collaborators |
Ethics + COI form completion | 1-2 hours | IRB ID, ICMJE COI for all authors |
Pre-submission checklist run-through | 60-90 minutes | The 12 items above |
Final submission package upload | 1 hour | Upload at https://mc.manuscriptcentral.com/jco |
Source: Manusights internal review of JCO-targeted submissions, 2025 cohort.
The bottleneck is usually the reference audit, especially for manuscripts with 80+ citations. Authors who skip this step often see retracted DOIs flagged in the desk-screen response 7-14 days after submission, which forces a full rework before resubmission.
Submit If
- The headline finding fits Journal of Clinical Oncology (ASCO)'s editorial scope (practice-changing oncology research) and the abstract names that fit within the first 100 words.
- The methods section is detailed enough for JCO reviewers to evaluate without follow-up; protocol and reproducibility detail are in the main text.
- All cited DOIs verified clean against Crossref + Retraction Watch (recent JCO-corpus retractions checked: 10.1200/JCO.21.02635).
- Reviewer-suggestion list contains 5 names from at least 3 different institutions, all active in the JCO reviewer pool.
Think Twice If
- The methods section relies on a single subgroup analysis or post-hoc figure to carry the headline claim that JCO reviewers will probe.
- The cover letter spends a paragraph on background before the new finding appears in the abstract; JCO's editorial culture treats this as a scope-fit warning.
- The reference list cites a paper that has since been retracted (recent JCO retractions include 10.1200/JCO.21.02635 and 10.1200/JCO.22.01128) without acknowledging the retraction notice.
- The protocol section relies on more than 3 figures of supplementary methodology that should be in the main text for JCO's reviewer pool.
Manusights submission-corpus signal for Journal of Clinical Oncology (ASCO). Of the manuscripts our team screened before submission to JCO and peer venues in 2025, the editorial-culture mismatch most consistent across the cohort is Jco editors enforce practice-changing threshold; preclinical-only oncology papers without clinical-translation pathway get desk-rejected. In our analysis of anonymized JCO-targeted submissions, the documented review timeline shows a bimodal distribution between manuscripts that clear JCO's scope-fit threshold within the first week and those that get extended editorial-board consultation. Recent retractions in the JCO corpus that should not appear in any submitted reference list: 10.1200/JCO.21.02635, 10.1200/JCO.22.01128.
- Manusights internal preview corpus (2025 cohort)
- SciRev community review-time data for JCO
Frequently asked questions
The 12 items below cover scope-fit, methods completeness, data and code availability, ethics declarations, reference cleanliness against retraction registries, cover letter framing, and reviewer-suggestion list quality. Each maps to a specific JCO desk-screen check.
For most JCO-targeted manuscripts, the full checklist takes 60-90 minutes if the underlying work is solid. Pages where authors uncover real issues during the checklist often take longer because fixes are needed before submission. The time saved on revision rounds outweighs the upfront verification.
JCO's author guidelines list submission requirements but do not provide a checklist authors can verify item-by-item against editorial expectations. This guide fills that gap, grounded in pre-submission reviews on JCO-targeted manuscripts plus public author guidelines.
Fix it before you submit. Each item is a known desk-screen failure mode at JCO. Submitting with a known gap means the gap will be flagged in 1-2 weeks and you will lose the time to peer review.
Sources
- JCO author guidelines (accessed 2026-05-08)
- Crossref retraction registry (retracted-DOI checks against the JCO corpus, accessed 2026-05-08)
- Retraction Watch database (cross-checked JCO retractions, accessed 2026-05-08)
- ICMJE recommendations (ethics + COI requirements, accessed 2026-05-08)
Final step
Submitting to Journal of Clinical Oncology?
Run the Free Readiness Scan to see score, top issues, and journal-fit signals before you submit.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Same journal, next question
- Journal of Clinical Oncology Submission Guide: Editorial Screening Guide
- How to Avoid Desk Rejection at Journal of Clinical Oncology
- Journal of Clinical Oncology Submission Process: What Happens From Upload to First Decision
- Is Journal of Clinical Oncology a Good Journal? The ASCO Flagship for Practice-Changing Oncology
- JCO Impact Factor 2026: 41.9, Q1
- JCO Acceptance Rate: What the Number Means for Authors
Supporting reads
Conversion step
Submitting to Journal of Clinical Oncology?
Anthropic Privacy Partner. Zero-retention manuscript processing.